Article

Persistent SARS-CoV-2 Infection in Patients With Secondary Antibody Deficiency: Successful Clearance Following Combination Casirivimab and Imdevimab (REGN-COV2) Monoclonal Antibody Therapy

2021-11-01

Abstract excerpt

<title>Abstract</title> <p>Background There is growing evidence that antibody responses play a role in the resolution of SARS-CoV-2 infection. Patients with primary or secondary antibody deficiency are at increased risk of persistent infection. This challenging clinical scenario is associated with adverse patient outcome and potentially creates an ecological niche for the evolution of novel SARS-CoV-2 variants w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 29808211-68e7-5de5-8f3b-238656ebdabb
DOI: 10.21203/rs.3.rs-991639/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Persistent SARS-CoV-2 Infection in Patients With Secondary Antibody Deficiency: Successful Clearance Following Combination Casirivimab and Imdevimab (REGN-COV2) Monoclonal Antibody TherapyDOI 10.21203/rs.3.rs-991639/v1Read

SARS-CoV-2 evolution and evasion from multiple antibody treatments in a cancer patientSemantic proximity Read

Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.Semantic proximity Read

RECOMBINANT HUMAN MONOCLONAL ANTIBODIES CASIRIVIMAB/IMDEVIMAB USE IN INHIBITION OF THE SARS-CoV-2 VIRUS INFECTIONSemantic proximity Read

Complex intra-host SARS-CoV-2 evolution following monoclonal antibody pre-exposure prophylaxisSemantic proximity Read

Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergenceSemantic proximity Read

Long-term passaging of replication competent pseudo-typed SARS-CoV-2 reveals the antiviral breadth of monoclonal and bispecific antibody cocktailsSemantic proximity Read

Molecular Characterization of Persistent SARS-CoV-2 Infections in Immunocompromised Patients.Semantic proximity Read

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic LeukaemiaSemantic proximity Read

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.Semantic proximity Read

Immunobridging Analysis of Pemivibart for the Treatment of COVID-19 – A Therapeutic Gap for the Immune Compromised RemainsSemantic proximity Read

MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection <i>in vitro</i> and in a hamster model of COVID-19Semantic proximity Read

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD StudySemantic proximity Read